Breaking News

Bilcare Research Invests in Aclar Laminates

March 14, 2016

Invests in a new laminator at its Wilmington, DE facility

Bilcare Research Inc. has invested in a new laminator at its Wilmington, DE facility, allowing the company to offer moisture barrier Aclar laminates for stability packaging, line trial samples, as well as full commercial volumes.  
 
Part of the global Pharmaceutical Packaging Innovation (PPI) Business Unit of Bilcare Research AG, Bilcare Research offers a variety of mono and barrier blister films to the pharmaceutical packaging industry.
 
“This investment in a new laminating line is just the latest component of our continued growth strategy to meet the needs of the rapidly evolving business models of the global pharmaceutical industry.  We see increased demand across our entire range of Bilcare Aclar laminates, from both, ethical and generic pharmaceutical companies,” said Kevin Stevens, president and managing director of Bilcare Research. “The lamination line is a further execution of Bilcare’s strategic investment of €50 Million and is a natural progression to the industry-specific segregation project for our PPI production. The new capacity will be fully available before the end of 2016.”
blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision